As per the research conducted by GME, the Global Bioinformatics in IVD Testing Market size will grow from USD 84.5 Billion in 2021 to USD 98.5 Billion by 2026, with a CAGR value of 6.5%. The Bioinformatics in the IVD Testing market will witness substantial growth mainly due to factors such as increasing prevalence of chronic diseases, genetic disorders, rising geriatric population, growing awareness related to early disease diagnosis, government initiatives for funding research activities, and increasing product launch strategies in the industry